Furthermore, the TGA-approved dual glucose-dependent insulinotropic polypeptide/GLP-1 receptor agonist tirzepatide has some evidence of renal benefit, based on a post-hoc analysis of the SURPASS-4 trial findings
Novel targeted therapies for inflammatory bowel disease
If HRV wont stabilize, resting heart rate stays elevated, or sleep efficiency wont budge despite good timing and clean inputs, thats a physiology that isnt using what its given
The GLP-1 medications have known side effects but are largely safe based on experience with diabetic patients and well-tolerated by most people
While GLP-1 medications are powerful tools, they are not a magic fix for thyroid dysfunction itself
This overview synthesizes key findings on its cytoprotective mechanism and experimental applications in wound healing, tendon repair, gastrointestinal models, and angiomodulation